Global Differences in Disease Management Guidelines (LARS Session)

Virtual Moderator(s)

• 

  Eric Matteson, MD

  Mayo Clinic College of Medicine and Science
  Rochester, MN, United States

  Disclosure(s): Amgen Inc: DSMB for Amgen Clinical trial (Terminated, December 20, 2024); Crystalys Therapeutics Inc: DSMB for Crystalys Clinical trial (Ongoing); Horizon Therapeutics: DSMB for Horizon Clinical trial (Terminated, December 20, 2024)

Presentations:

• 2:10 PM – 2:30 PM Central Time

  Takayasu Disease Management Guidelines
  

  Virtual Speaker: Haner Direskeneli, MD – Marmara University
• 2:30 PM – 2:50 PM Central Time

  ACR Disease Management Guideline Process- RA
• 2:50 PM – 3:00 PM Central Time

  Introduction to Panelists
  

  Virtual Moderator: Eric Matteson, MD – Mayo Clinic College of Medicine and Science
• 3:00 PM – 3:50 PM Central Time

  PANEL Discussion
  

  Virtual Panelist: Bernhard Hellmich, MD – Medius Kliniken

  Virtual Panelist: Gilda Ferreira, PhD – Federal University of Minas Gerais

  Virtual Panelist: Chi Chiu Mok, MD,FRCP – Tuen Mun Hospital
• 3:50 PM – 4:00 PM Central Time

  Closing Remarks
  

  Virtual Moderator: Eric Matteson, MD – Mayo Clinic College of Medicine and Science